RxSight, Inc. (RXST) stock
RXSTNasdaqOphthalmic GoodsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 3, 2026Score 10/3076% below fair value
$5.01+0.18 (+3.73%)
Close on Nov 18, 2026Market cap $208.38MP/E –Yield –
RxSight net income
Net income is the profit left for shareholders after every expense, interest and tax.
RxSight's net income for the twelve months ending Jun 30, 2026 was -$46.95M. For fiscal 2025 it was -$38.94M. The highest annual figure on record is $27.58M in fiscal 2020.
Annual net income
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | -$38.94M | – |
| FY2024 | Dec 31, 2024 | -$27.46M | – |
| FY2023 | Dec 31, 2023 | -$48.61M | – |
| FY2022 | Dec 31, 2022 | -$66.76M | – |
| FY2021 | Dec 31, 2021 | -$48.69M | -276.6% |
| FY2020 | Dec 31, 2020 | $27.58M | – |
Quarterly net income
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q2 FY2026 | Jun 30, 2026 | -$12.10M | – |
| Q1 FY2026 | Mar 31, 2026 | -$15.88M | – |
| Q4 FY2025 | Dec 31, 2025 | -$9.15M | – |
| Q3 FY2025 | Sep 30, 2025 | -$9.82M | – |
| Q2 FY2025 | Jun 30, 2025 | -$11.79M | – |
| Q1 FY2025 | Mar 31, 2025 | -$8.19M | – |
| Q4 FY2024 | Dec 31, 2024 | -$5.94M | – |
| Q3 FY2024 | Sep 30, 2024 | -$6.34M | – |
| Q2 FY2024 | Jun 30, 2024 | -$6.08M | – |
| Q1 FY2024 | Mar 31, 2024 | -$9.10M | – |
| Q4 FY2023 | Dec 31, 2023 | -$9.18M | – |
| Q3 FY2023 | Sep 30, 2023 | -$12.42M | – |
| Q2 FY2023 | Jun 30, 2023 | -$13.80M | – |
| Q1 FY2023 | Mar 31, 2023 | -$13.21M | – |
| Q4 FY2022 | Dec 31, 2022 | -$15.61M | – |
| Q3 FY2022 | Sep 30, 2022 | -$16.82M | – |
| Q2 FY2022 | Jun 30, 2022 | -$16.73M | – |
| Q1 FY2022 | Mar 31, 2022 | -$17.60M | – |
| Q4 FY2021 | Dec 31, 2021 | -$15.73M | -159.8% |
| Q3 FY2021 | Sep 30, 2021 | -$12.67M | -141.3% |
| Q2 FY2021 | Jun 30, 2021 | -$13.48M | – |
| Q1 FY2021 | Mar 31, 2021 | -$6.81M | – |
| Q4 FY2020 | Dec 31, 2020 | $26.30M | – |
| Q3 FY2020 | Sep 30, 2020 | $30.66M | – |
| Q2 FY2020 | Jun 30, 2020 | -$12.88M | – |
| Q1 FY2020 | Mar 31, 2020 | -$16.50M | – |
See a number that looks wrong?